Details for New Drug Application (NDA): 218554
✉ Email this page to a colleague
The generic ingredient in NELARABINE is nelarabine. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the nelarabine profile page.
Summary for 218554
Tradename: | NELARABINE |
Applicant: | Alembic |
Ingredient: | nelarabine |
Patents: | 0 |
Pharmacology for NDA: 218554
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Suppliers and Packaging for NDA: 218554
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 218554 | ANDA | Alembic Pharmaceuticals Limited | 46708-813 | 46708-813-50 | 1 VIAL in 1 CARTON (46708-813-50) / 50 mL in 1 VIAL |
NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 218554 | ANDA | Alembic Pharmaceuticals Limited | 46708-813 | 46708-813-63 | 6 VIAL in 1 CARTON (46708-813-63) / 50 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 250MG/50ML (5MG/ML) | ||||
Approval Date: | Aug 1, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription